Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001307561 | SCV001496977 | uncertain significance | Severe combined immunodeficiency due to DNA-PKcs deficiency | 2020-08-14 | criteria provided, single submitter | clinical testing | Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with PRKDC-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 433 of the PRKDC protein (p.Pro433Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. |
Ambry Genetics | RCV004847795 | SCV005479488 | uncertain significance | not specified | 2024-06-29 | criteria provided, single submitter | clinical testing | The p.P433L variant (also known as c.1298C>T), located in coding exon 13 of the PRKDC gene, results from a C to T substitution at nucleotide position 1298. The proline at codon 433 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |